Mirae Asset Global Etfs Holdings Ltd. Arcturus Therapeutics Holdings Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 14,326 shares of ARCT stock, worth $281,219. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,326Holding current value
$281,219% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARCT
# of Institutions
189Shares Held
27.4MCall Options Held
320KPut Options Held
153K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$92.1 Million0.28% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$52 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.32MShares$45.4 Million0.62% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.28MShares$44.7 Million0.04% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.1MShares$41.2 Million0.46% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $522M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...